Splash Beverage Group (SBEV) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
12 Jun, 2026Company overview and business model
Historically focused on acquiring and building early-stage or undervalued beverage brands with growth potential, but currently only distributes Chispo tequila due to lack of working capital and unsuccessful commercialization efforts.
Generated minimal revenue in Q1 2026 from a single customer, which has since terminated its contract; no revenue in Q2 2026.
Transitioning strategic focus to the regulated wellness and cannabinoid markets, including potential acquisitions in the CBD and wellness sectors.
Principal offices in Fort Lauderdale, Nevada incorporation, and listed on NYSE American under the symbol SBEV.
Financial performance and metrics
Revenues for the year ended December 31, 2025 were $0.07 million, down from $0.8 million in 2024, primarily due to lack of operating capital.
Net loss from continuing operations was approximately $25.2 million for 2025, including $14.2 million in non-cash items.
Operating expenses increased to $14.2 million in 2025, mainly due to $8.6 million in non-cash share-based compensation.
As of March 31, 2026, cash and cash equivalents were $381,195, with a working capital deficit and insufficient capital for the next 12 months.
Auditors included a going concern paragraph due to recurring losses, negative cash flows, and accumulated deficit.
Use of proceeds and capital allocation
May receive up to $32.16 million in gross proceeds from the equity line of credit (ELOC) with C/M Capital Master Fund, LP, depending on shares sold and market price.
Proceeds intended for working capital, general corporate purposes, strategic pivot into cannabinoid wellness, closing an accretive transaction, and achieving NYSE compliance.
30% of proceeds above $3 million from the ELOC must be used to repay outstanding promissory notes to C/M and affiliates.
Management retains broad discretion over allocation of net proceeds.
Latest events from Splash Beverage Group
- Severe revenue decline, liquidity risk, and pending Medterra deal threaten NYSE listing.SBEV
Q1 202620 May 2026 - Paused operations, major losses, and a planned Medterra CBD acquisition amid severe liquidity risk.SBEV
Q4 202515 Apr 2026 - Shareholders approved increasing authorized common shares to 400 million.SBEV
AGM 20253 Feb 2026 - Revenue plunged and losses persisted amid liquidity and NYSE compliance risks.SBEV
Q2 20243 Feb 2026 - Gross margins improved to 30% as revenue fell and liquidity risks persisted.SBEV
Q3 202412 Jan 2026 - Severe liquidity crisis and no revenue drive urgent capital raise and major dilution risk.SBEV
Registration Filing22 Dec 2025 - Distressed beverage company seeks $35M ELOC, faces dilution and going concern risks.SBEV
Registration Filing18 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and major share issuances.SBEV
Proxy Filing1 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and key share issuances.SBEV
Proxy Filing1 Dec 2025